Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DSI acquires Redi Rx from Diversified Healthcare Services
The Redi Rx sales and Atlanta-based customer service team led by Daniel Hauck will come on board to continue as part of the Dispensing Solutions (DSI) team. DSI’s
The Redi Rx sales and Atlanta-based customer service team led by Daniel Hauck will come on board to continue as part of the Dispensing Solutions (DSI) team. DSI’s
Dr Holland is currently scientific director of Delta Blood Bank in Stockton, California. Mr Clouser, currently a consultant, served for many years as president, CEO and a board
PharmaVigilant’s I-Warehouse 2.0 incorporates several new important features that include data on demand, incorporation of meta-data into the I-Warehouse, as well as the ability to reconcile and query
Under the acquisition, FiberLite will be integrated into Thermo Fisher’s laboratory products and services segment. Centrifuge models range from bench-top microcentrifuges to floor-standing ultracentrifuges, allowing Thermo Fisher Scientific
Eisai’s Fospropofol disodium injection has been in review at the FDA for use as an intravenous sedative-hypnotic agent for sedation in adult patients undergoing diagnostic or therapeutic procedures.
Interim results from Genaera’s second Phase I clinical trial of MSI-1436, a novel inhibitor of PTP1B, demonstrated that the drug was well-tolerated by the overweight and obese volunteers
These agreements have an initial term to 2011 and effectively extend and strengthen existing distribution arrangements, giving Abbott and PSS exclusive marketing rights to the Afinion system in
Mr Feldman will begin his new role on August 11, 2008, and will report to Marsha Powers, senior vice president of regional operations for Tenet’s Florida region. Mr
Mr Long had served as Chattem’s vice president of finance since July 2007 and as its chief accounting officer from April 2006 to July 2007. Prior to joining
The Committee for Medicinal Products for Human Use’s (CHMP) positive opinion for Evicel will now be forwarded to the European Commission for marketing authorization, which is expected by